Invesco
GRTS

Invesco’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Invesco’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-55,033
Closed -$141K – 4000
2024
Q1 		$141K Sell
55,033
-10,452
-16% -$25.5K ﹤0.01% 3707
2023
Q4 		$134K Buy
65,485
+11,908
+22% +$21.7K ﹤0.01% 3643
2023
Q3 		$92.2K Buy
53,577
+852
+2% +$1.51K ﹤0.01% 3729
2023
Q2 		$103K Buy
+52,725
New +$123K ﹤0.01% 3722
2022
Q2 		– Sell
-13,885
Closed -$57K – 4174
2022
Q1 		$57K Sell
13,885
-730,715
-98% -$3.87M ﹤0.01% 3920
2021
Q4 		$9.58M Buy
744,600
+331,662
+80% +$3.67M ﹤0.01% 2039
2021
Q3 		$4.46M Buy
412,938
+208,516
+102% +$1.9M ﹤0.01% 2449
2021
Q2 		$1.87M Buy
+204,422
New +$1.89M ﹤0.01% 2884

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Invesco's GRTS Position: Q2 2024 in Review

Invesco sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2024, closing a stake of 55,033 shares — an estimated $141K sold.

Invesco first reported a position in GRTS in Q2 2021 and held it in 8 quarters. The position peaked at $9.58M in Q4 2021. 79 funds tracked by Wall St. Rank hold GRTS as of Q2 2024.

  • Invesco reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Invesco sold 55,033 Gritstone bio, Inc. Common Stock shares in Q2 2024, an estimated $141K.
  • Invesco first reported a position in Gritstone bio, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Invesco's Gritstone bio, Inc. Common Stock position peaked at $9.58M in Q4 2021.
  • 79 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2024.

Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.